Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis

RJ Malloy, AO Kanaan, MA Silva, JL Donovan - Clinical therapeutics, 2013 - Elsevier
Background The current guidelines recommend various antiplatelet agents used alone or in
combination for secondary prevention of noncardioembolic stroke. Objective The purpose of …
被引用次数：42 相关文章

[引用][C] Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis

RJ MALLOY, AO KANAAN, MA SILVA… - Clinical …, 2013 - pascal-francis.inist.fr
Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment
Comparison Meta-analysis CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis

RJ Malloy, AO Kanaan, MA Silva, JL Donovan - Clinical Therapeutics, 2013 - infona.pl
The current guidelines recommend various antiplatelet agents used alone or in combination
for secondary prevention of noncardioembolic stroke. The purpose of this study was to …

Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis

RJ Malloy, AO Kanaan, MA Silva… - Clinical …, 2013 - clinicaltherapeutics.com
Background The current guidelines recommend various antiplatelet agents used alone or in
combination for secondary prevention of noncardioembolic stroke. Objective The purpose of …

Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.

RJ Malloy, AO Kanaan, MA Silva… - Clinical Therapeutics, 2013 - europepmc.org
Background The current guidelines recommend various antiplatelet agents used alone or in
combination for secondary prevention of noncardioembolic stroke. Objective The purpose of …

Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis

RJ Malloy, AO Kanaan, MA Silva… - Clinical …, 2013 - pubmed.ncbi.nlm.nih.gov
Background The current guidelines recommend various antiplatelet agents used alone or in
combination for secondary prevention of noncardioembolic stroke. Objective The purpose of …

Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis

RJ Malloy, AO Kanaan, MA Silva, JL Donovan - Clinical Therapeutics, 2013 - infona.pl
The current guidelines recommend various antiplatelet agents used alone or in combination
for secondary prevention of noncardioembolic stroke. The purpose of this study was to …

[引用][C] Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis

RJ Malloy, AO Kanaan, MA Silva… - Clinical Therapeutics, 2013 - Elsevier Limited